128 related articles for article (PubMed ID: 37775402)
1. Characteristics and Outcomes of De Novo Genitourinary Malignancy in Solid Organ Transplant Recipients at the University of Minnesota.
Cleveland B; Gardeck A; Holten M; Jiang S; Jackson S; Pruett T; Warlick C
Transplant Proc; 2023 Nov; 55(9):2027-2034. PubMed ID: 37775402
[TBL] [Abstract][Full Text] [Related]
2. Risk of Genitourinary Malignancy in the Renal Transplant Patient.
Jiang S; Regmi S; Jackson S; Calvert C; Jarosek S; Pruett T; Warlick C
Urology; 2020 Nov; 145():152-158. PubMed ID: 32763322
[TBL] [Abstract][Full Text] [Related]
3. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Bhat M; Mara K; Dierkhising R; Watt KDS
Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
[TBL] [Abstract][Full Text] [Related]
5. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
[TBL] [Abstract][Full Text] [Related]
6. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
[TBL] [Abstract][Full Text] [Related]
7. Cancer incidence in immunocompromised patients: a single-center cohort study.
Ilham S; Willis C; Kim K; Chung KC; Wood BM; Tan MS; Tan CJ; Nguyen DT; Brixner DI; Stenehjem DD
BMC Cancer; 2023 Jan; 23(1):33. PubMed ID: 36624408
[TBL] [Abstract][Full Text] [Related]
8. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
Miao Y; Everly JJ; Gross TG; Tevar AD; First MR; Alloway RR; Woodle ES
Transplantation; 2009 May; 87(9):1347-59. PubMed ID: 19424035
[TBL] [Abstract][Full Text] [Related]
9. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
10. De novo malignancy in heart transplant recipients: A single center experience in Japan.
Kimura Y; Yanase M; Mochizuki H; Iwasaki K; Toda K; Matsuda S; Takenaka H; Kumai Y; Kuroda K; Nakajima S; Watanabe T; Ikura MM; Wada K; Matsumoto Y; Seguchi O; Fukushima S; Fujita T; Kobayashi J; Fukushima N
J Cardiol; 2019 Mar; 73(3):255-261. PubMed ID: 30587457
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
Lu K; Chiu KY
Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
[TBL] [Abstract][Full Text] [Related]
12. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of De Novo Malignancy After Liver Transplant: A Single-Center Study.
Kim S; Rovgaliyev B; Lee JM; Lee KW; Hong SK; Cho JH; Yoon KC; Yi NJ; Suh KS
Transplant Proc; 2021; 53(1):200-206. PubMed ID: 32409224
[TBL] [Abstract][Full Text] [Related]
14. Sepsis outcomes in solid organ transplant recipients.
Gotur DB; Masud FN; Ezeana CF; Nisar T; Paranilam J; Chen S; Puppala M; Wong STC; Zimmerman JL
Transpl Infect Dis; 2020 Feb; 22(1):e13214. PubMed ID: 31755202
[TBL] [Abstract][Full Text] [Related]
15. Lung Cancer Prognosis in Elderly Solid Organ Transplant Recipients.
Sigel K; Veluswamy R; Krauskopf K; Mehrotra A; Mhango G; Sigel C; Wisnivesky J
Transplantation; 2015 Oct; 99(10):2181-9. PubMed ID: 25839704
[TBL] [Abstract][Full Text] [Related]
16. National survey of de novo malignancy after solid organ transplantation in Japan.
Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
[TBL] [Abstract][Full Text] [Related]
17. Mortality among solid organ transplant recipients with a pretransplant cancer diagnosis.
Hart A; Pfeiffer RM; Morawski BM; Lynch CF; Zeng Y; Pawlish K; Hurley D; Yu KJ; Engels EA
Am J Transplant; 2023 Feb; 23(2):257-264. PubMed ID: 36804133
[TBL] [Abstract][Full Text] [Related]
18. Genitourinary malignancies in solid organ transplant recipients.
Muruve NA; Shoskes DA
Transplantation; 2005 Sep; 80(6):709-16. PubMed ID: 16210955
[TBL] [Abstract][Full Text] [Related]
19. "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation".
Wareham NE; Li Q; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Perch M; Rasmussen A; Sørensen SS; Mocroft A; Lundgren JD
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3125-3135. PubMed ID: 31587105
[TBL] [Abstract][Full Text] [Related]
20. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
